SKI Market

Indian Indices

Nifty

24,487.40 -97.65
(-0.40%)

Sensex

80,235.59 -368.49
( -0.46%)

Bank Nifty

55,043.70 -467.05
( -0.84%)

Nifty IT

34,674.30 129.65
( 0.38%)

Global Indices

Nasdaq

44,012.84 -183.78
(-0.42%)

Dow Jones

6,397.00 13.45
(-0.21%)

Hang Seng

42,778.56 958.08
(2.29%)

Nikkei 225

9,129.71 33.98
(0.37%)

Forex

USD-INR

87.65 0.09
(0.10%)

EUR-INR

102.02 -0.05
(-0.04%)

GBP-INR

117.85 0.54
(0.46%)

JPY-INR

0.59 0.00
(-0.24%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Lyka Labs Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500259

INE933A01014

37.8091622

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

LYKALABS

51.13

372.25

EPS(TTM)

Face Value()

Div & Yield %

2.04

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	134.70	106.40	80.59	164.35	62.26	40.74
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	134.70	106.40	80.59	164.35	62.26	40.74
Other Income	2.34	1.65	3.45	2.72	2.21	4.34
Stock Adjustments	1.37	0.79	1.21	0.40	-2.04	0.28
Total Income	138.41	108.84	85.25	167.47	62.43	45.36
EXPENDITURE :
Raw Materials	54.60	43.73	30.27	31.27	21.48	21.30
Power & Fuel Cost	3.90	3.92	3.57	3.88	2.91	2.52
Employee Cost	34.09	26.01	17.48	16.22	13.03	11.71
Other Manufacturing Expenses	5.22	4.49	2.81	2.25	2.27	1.40
Selling & Administrative Expenses	18.99	13.20	11.18	12.04	5.63	5.43
Miscellaneous Expenses	1.39	1.33	8.06	6.26	1.91	31.38
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	118.19	92.68	73.37	71.93	47.22	73.74
Operating Profit	20.23	16.15	11.88	95.55	15.20	-28.37
Interest	2.30	4.80	11.57	19.92	25.55	19.01
Gross Profit	17.93	11.35	0.31	75.63	-10.35	-47.38
Depreciation	6.45	12.29	13.52	15.39	8.05	7.77
Profit Before Tax	11.48	-0.94	-13.21	60.24	-18.40	-55.15
Tax	2.72	1.60	0.21	0.00	0.00	0.00
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.52	-0.26	-0.13	20.34	-3.94	0.24
Reported Net Profit	8.23	-2.27	-13.29	39.90	-14.46	-55.39
Extraordinary Items	0.00	0.04	-7.06	-3.09	-1.43	-27.63
Adjusted Net Profit	8.23	-2.31	-6.23	42.99	-13.03	-27.76
Adjustment below Net Profit	0.00	0.00	0.00	0.00	0.00	0.00
P & L Balance brought forward	-103.65	-101.38	-88.09	-127.99	-113.54	-58.15
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
P & L Balance carried down	-95.42	-103.65	-101.38	-88.09	-127.99	-113.54
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Per Share(Rs)	0.00	0.00	0.00	0.00	0.00	0.00
Earnings Per Share-Unit Curr	2.31	-0.69	-4.33	13.91	-5.04	-19.31
Earnings Per Share(Adj)-Unit Curr	2.31	-0.69	-4.33	13.91	-5.04	-19.31
Book Value-Unit Curr	37.81	27.28	19.22	15.49	1.54	6.55
Book Value(Adj)-Unit Curr	37.81	27.28	19.22	15.49	1.54	6.55

24,487.40 -97.65 (-0.40%)

80,235.59 -368.49 ( -0.46%)

55,043.70 -467.05 ( -0.84%)

34,674.30 129.65 ( 0.38%)

44,012.84 -183.78 (-0.42%)

6,397.00 13.45 (-0.21%)

42,778.56 958.08 (2.29%)

9,129.71 33.98 (0.37%)

87.65 0.09 (0.10%)

102.02 -0.05 (-0.04%)

117.85 0.54 (0.46%)

0.59 0.00 (-0.24%)